Tyrosine Kinase Receptor - Cancer Science

Relevant Publications

Cardiovascular disease burden in patients with urological cancers: The new discipline of uro-cardio-oncology.

Issue Release: 2024

Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis.

Issue Release: 2024

Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway.

Issue Release: 2024

FAK inhibitors in cancer, a patent review - an update on progress.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

Clinical Characteristics and Outcomes of Generalized Myasthenia Gravis in Malaysia: A Single-Center Experience.

Issue Release: 2024

Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide-Drug Conjugates for Targeted Cancer Therapy.

Issue Release: 2024

Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments.

Issue Release: 2024

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy.

Issue Release: 2024

Transmembrane helix interactions regulate oligomerization of the receptor tyrosine kinase EphA2.

Issue Release: 2024

DNA Mutational and Copy Number Variation Profiling of Primary Craniofacial Osteosarcomas by Next-Generation Sequencing.

Issue Release: 2024

The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.

Issue Release: 2024

Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023.

Issue Release: 2024

Probing phosphorylation events in biological membranes: The transducer function.

Issue Release: 2024

Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis.

Issue Release: 2024

Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies.

Issue Release: 2024

3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer.

Issue Release: 2024

Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

Analysis of serum proteomic profiles of endangered Siamese and Burmese Eld\'s Deer infected with subclinical Babesia bovis in Thailand.

Issue Release: 2024

What Are the Challenges in Treating Cancer in HIV-Positive Patients?

How Can Researchers and Companies Leverage USPTO Resources?

What are the Challenges in Targeting Nuclear Receptors?

How Can Intuition Help in Early Detection?

What is the Impact of Lifestyle on Cancer Outcomes?

What are the Challenges in Targeting Enzymes for Cancer Therapy?

What are Cancer Advocacy Organizations?

What is Stress Testing?

Why is Spatial Distribution Important?

Who Should Consider Genetic Testing for Cancer?

Partnered Content Networks

Relevant Topics